loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 211367 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 EXELTIS USA INC (1)

filter

01 TABLET;ORAL (1)

filter

01 RX (1)

filter

01 SLYND (1)

filter

01 Yes (1)

URL Supplier Web Content
TABLET; ORAL
4MG
2019-05-23
211367
SLYND
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 211367

Looking for FDA Orange Book APPLICATION 211367 1

19

Exeltis, based in Spain, is a pharmaceutical company.

One of their notable products is DROSPIRENONE, with a corresponding application number 211367.

Regulatory Information RX

With a dosage strength 4MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2019-05-23

Post Enquiry
POST ENQUIRY